原文標題： 川普稱藥品關稅最終可能達到250% ※請勿刪減原文標題 原文連結： https://reurl.cc/XQE7g0 ※網址超過一行過長請用縮網址工具 發布時間： AUG 5 20258:30 AM EDT ※請以原文網頁/報紙之發布時間為準 記者署名： Annika Kim Constantino ※原文無記載者得留空 原文內容： President Donald Trump told CNBC’s “Squawk Box” on Tuesday that planned tarif fs on pharmaceuticals imported into the U.S. could eventually reach up to 250%, the highest rate he has threatened so far. He said he will initially impose a ? small tariff” on pharmaceuticals, but then in a year to a year and a half “max imum,” he will raise that rate to 150% and then 250%. The president has repeat edly threatened and then changed course on tariff proposals, so there’s no guar antee he will eventually set pharmaceutical tariffs at the 250% rate. In early J uly, Trump had threatened 200% tariffs on pharmaceuticals. The Trump administra tion in April initiated a so-called Section 232 investigation on pharmaceutical products. That’s a legal authority that allows the secretary of Commerce to inv estigate the impact of imports on national security. The tariffs are the presid ent’s bid to incentivize drug companies to move manufacturing operations to the U.S. at a time when domestic drug manufacturing has shrunk dramatically over th e last few decades. Over the last six months, companies like Eli Lilly and John son & Johnson have announced fresh U.S. investments to build goodwill with the president. “We want pharmaceuticals made in our country,” Trump told CNBC. T he planned levies would deal a blow to the pharmaceutical industry, which has wa rned that the tariffs could drive up costs, deter investments in the U.S. and di srupt the drug supply chain, putting patients at risk. Drugmakers are already na vigating the fallout from Trump’s drug pricing policies, which they argue threa ten both their bottom lines and their capacity to invest in research and develop ment. That includes Trump’s executive order in May that revives a controversia l plan, the “most favored nation” policy, that aims to slash drug costs by tyi ng the prices of some medicines in the U.S. to the significantly lower ones abro ad. On Tuesday, Trump told CNBC that he “invoked” the “most favored nations? policy and that it will have a “tremendous impact on the price of medicine.” But Trump has not officially implemented any changes from the executive order. Trump last week sent letters to 17 drugmakers calling on them to commit to steps to lower U.S. drug prices by Sept. 29. That includes agreeing to provide their full portfolio of existing medicines at the lowest price offered in other develo ped nations to every single Medicaid patient, among other steps. Some pharmaceu tical companies have said they are reviewing the letters. 川普總統週二在 CNBC 節目《Squawk Box》中表示，擬針對進口到美國的藥品徵收的關稅， 最終可能高達 250%，這是他迄今為止威脅的最高稅率。 他說，最初會對藥品徵收「小額關稅」，但在一年到一年半「最長」時間內，他將把稅率先 提高到 150%，然後再調升至 250%。 總統多次威脅過藥品關稅，卻又改變決策，因此並不保證他最終真的會將藥品關稅設定為 2 50%。在七月初，川普曾威脅要對藥品徵收 200% 的關稅。 川普政府在四月份啟動了所謂的「232條款」調查，針對藥品進口進行調查。該條款授權商? 部長評估進口品對國家安全的影響。 這些關稅是總統為了鼓勵藥廠將製造業務移回美國所提出的策略，因為過去幾十年來，美國 國內的藥品製造業大幅萎縮。過去六個月內，諸如禮來（Eli Lilly）和強生（Johnson & J ohnson）等公司都已宣布新的美國投資，以示對總統的善意。 「我們要讓藥品在我們國內製造，」川普在 CNBC 上表示。 這些擬議徵稅將對製藥業造成打擊，藥廠警告說，此舉可能推高成本、抑制美國投資，並擾 亂藥品供應鏈，危及病患用藥安全。藥廠已在應對川普的藥價政策衝擊，他們認為這些政策 既威脅利潤，也影響研發投資。 其中就包括川普在五月簽署的行政命令，重新啟動具爭議的「最惠國」政策，旨在將部分美 國藥品價格與其他國家顯著較低的藥價掛鉤，以大幅削減藥價。 週二，川普告訴 CNBC，他已「引用」最惠國政策，並認為此舉將對藥價產生「巨大影響」? 不過，川普尚未正式落實該行政命令中的任何變更。 上週，川普向 17 家藥廠寄發信函，要求它們在 9 月 29 日前承諾採取措施降低美國藥價? 包括同意將其現有全線藥品的最低海外價格，提供給所有單一的聯邦醫療補助 (Medicaid) 患者等多項做法。 一些製藥公司表示正在審閱這些信函。 心得/評論： 主委越來越聰明了欸 說警告妳說一年後沒來就250% 藥品是這樣 看來半導體也一樣 先警告你一年後你沒到自己看著辦 不過台積最近比較危險還是外流 有買的自己加油 ※必需填寫滿30正體中文字，無意義者板規處分 ---- Sent from BePTT on my iPhone 12 Pro --

※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 223.137.110.201 (臺灣) ※ 文章網址: https://webptt.com/m.aspx?n=bbs/Stock/M.1754400554.A.432.html ※ 編輯: c259888 (223.137.110.201 臺灣), 08/05/2025 21:31:29 重點是其他競爭者都跟你一樣不去？ 還是他們去你沒去 他沒關稅你250% 你競爭力直接歸零 ※ 編輯: c259888 (223.137.110.201 臺灣), 08/05/2025 21:34:26